Kennedy Capital Management’s Haemonetics HAE Stock Holding History

Kennedy Capital Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-60,635	Closed	-$2.12M	–	761
2014 Q3	$2.12M	Sell	60,635 -189,506	-76%	-$6.76M	0.04%	552
2014 Q2	$8.82M	Sell	250,141 -21,778	-8%	-$727K	0.16%	232
2014 Q1	$8.86M	Sell	271,919 -5,416	-2%	-$207K	0.17%	233
2013 Q4	$11.7M	Sell	277,335 -44,123	-14%	-$1.82M	0.22%	151
2013 Q3	$12.8M	Sell	321,458 -11,953	-4%	-$501K	0.25%	117
2013 Q2	$13.8M	Buy	+333,411	New	+$13.5M	0.28%	100

Other funds holding HAE

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Kennedy Capital Management's HAE Position: Q4 2014 in Review

Kennedy Capital Management sold out of Haemonetics (HAE) in Q4 2014, closing a stake of 60,635 shares — an estimated $2.12M sold.

Kennedy Capital Management first reported a position in HAE in Q2 2013 and held it in 6 quarters. The position peaked at $13.8M in Q2 2013. 172 funds tracked by Wall St. Rank hold HAE as of Q4 2014.

Kennedy Capital Management reported no remaining Haemonetics position as of Q4 2014 after selling out during the quarter.
Kennedy Capital Management sold 60,635 Haemonetics shares in Q4 2014, an estimated $2.12M.
Kennedy Capital Management first reported a position in Haemonetics in Q2 2013 and held it in 6 quarters.
Kennedy Capital Management's Haemonetics position peaked at $13.8M in Q2 2013.
172 funds tracked by Wall St. Rank held Haemonetics as of Q4 2014.

Based on Kennedy Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.